Long‐term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine
Haruhiko Kobashi(Tsuyama Chuo Hospital), Kazuhide Yamamoto(Kurume University Medical Center), Tetsuya Yasunaka(Okayama University), Gotaro Yamada(Shinshu University), Jyunichi Kubota(Tsuyama Chuo Hospital), Akinobu Takaki(Okayama University), Yasuhiro Miyake(High Energy Accelerator Research Organization), Fusao Ikeda(Okayama University), Ken Nishino(Kawasaki Hospital), Kazuhiro Nouso(Okayama Prefecture), Shinichiro Nakamura(Himeji Red Cross Hospital), Akio Moriya(Kawasaki Hospital)
Cited by 43
Related Papers
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
A new approach for measuring the muon anomalous magnetic moment and electric dipole moment
|Progress of Theoretical and Experimental Physics|2019|239
Sensitivity and Specificity of Des-Gamma-Carboxy Prothrombin for Diagnosis of Patients with Hepatocellular Carcinomas Varies According to Tumor Size
|The American Journal of Gastroenterology|2006|165